Abstract
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases which play essential roles in extracellular matrix (ECM) remodeling. Among them, MMP-2 and MMP-9 are mainly associated with tumor invasion, angiogenesis, metastasis, and other pathological processes such as fibrosis and inflammation, making them attractive therapeutic targets for cancer treatment. Marine natural products, particularly seaweed-derived bioactive compounds, have attracted increasing attention because of their structural diversity, broad pharmacological activities, and generally favorable biocompatibility. Seaweeds are a rich source of polysaccharides, phenolic compounds, fatty acids, pigments, vitamins, and other metabolites with anti-inflammatory, anti-oxidant, and anti-cancer properties. Growing evidence indicates that several of these compounds could suppress cancer cell proliferation, invasion, migration, and metastasis by regulating the activity and/or expression of MMP-2 and MMP-9 and their associated signaling pathways, including MAPK signaling pathways. This review comprehensively summarizes current evidence on seaweed-derived bioactive compounds as modulators of MMP 2 and MMP-9 with particular emphasis on their effects on enzymatic activity, expression, and MMP-associated signaling pathways. In addition, current limitations, translational challenges, and future perspectives for developing seaweed-derived compounds as potential MMP-targeted strategies for cancer prevention and therapy are discussed.
Funding Information
  • National Research Foundation of Korea (RS-2026-25598252)
  • Kongju National University
  • Ministry of Education (2026-ANCHOR-12-003)

This publication has 153 references indexed in Scilit: